The value of colorectal cancer (CRC) screening lies in CRC prevention through polyp detection and prevention of CRC mortality by early-stage CRC detection. Compared with
FIT
FIT
Cancers Detected in Second-Round Fecal Immunochemical Test Screening Still Early Stage
Delay in Colonoscopy After Positive FIT May Be Lethal, Particularly in 40- to 49-Year-Olds
These data are from a population-based Chinese screening program involving 595,180 persons aged 40 to 74 years with 16 years of follow-up. There were 42,353
Offering a Blood Test Increases CRC Screening in Patients Who Had Declined Colonoscopy and FIT
This was a randomized controlled trial in 359 veterans aged 50 to 75 years who had declined colonoscopy and a fecal immunochemical test (FIT) in
Anticoagulant and Antiplatelet Agents Affect Fecal Immunochemical Test Performance
In a very large study, 11.8% of 77,007 patients receiving antithrombotic treatment had a positive fecal immunochemical test (FIT) result, compared with 6% of those
Colorectal Cancer Screening Rates Increased During the COVID Pandemic, but With Stool-based Tests, Not Colonoscopy
This report is from the National Health Interview Survey, an annual survey of U.S. households covering a wide range of health topics. Response rates were
Is There an Increased Risk of Proximal Gastrointestinal Cancer After a Positive Fecal Immunochemical Test?
The fecal immunochemical test (FIT) is a simple, noninvasive, at-home study that detects blood in the stool and is used for colon cancer (CRC) screening
ADR Works in FIT-Positive Populations: Target ADR Must Be Substantially Higher Than Primary Screening ADR
It is well known that the prevalence of adenomas is higher in patients with a positive result from a stool test, including both the fecal
Dutch Describe Impact of Their National Biennial Fecal Immunochemical Test Screening Program
In 2014, the Netherlands instituted a national program of every-other-year fecal immunochemical test (FIT) screening for colorectal cancer (CRC). Since the start of screening, within
Risk-Stratified CRC Screening Using Fecal Immunochemical Test and Stool DNA
This is a post hoc analysis of a risk-stratification screening strategy based on the Asia-Pacific Colorectal Screening (APCS) scoring system. This score ranks patients as
Adenoma Detection Rate Says It All in FIT-Positive Patients
This is a study of detection indicators in 13,067 fecal immunochemical test (FIT)-positive colonoscopies performed by 80 community gastroenterologists. The cutoff for FIT positivity was
Actual Impact of COVID-19 on CRC (8.7% Reduction) and Advanced Adenoma (26.9% Reduction) Diagnoses in a U.S. Health Care System
This study utilized the Kaiser Permanente Northern California (KPNC) health care system to evaluate the actual impact of the COVID-19 pandemic on colorectal cancer (CRC).
Computer-Aided Detection Improves Adenoma Detection Rate and Adenomas Per Colonoscopy in Fecal Immunochemical Test-Positive Patients
In parallel-arm randomized trials involving mostly primary screening and surveillance colonoscopy patients, computer-aided detection (CADe) has increased the adenoma detection rate (ADR) by about 10%.
Systematic Review and Meta-analysis of Adenoma Detection Rates in FIT-positive Patients
The U.S. Multi-Society Task Force on Colorectal Cancer recommends minimally acceptable adenoma detection rates (ADRs) in primary screening colonoscopy of 30% in men and 20%
The Veterans Health Administration Instituted a National Policy Converting Screening Colonoscopy to FIT During the COVID Pandemic: Was the Policy Followed?
During the COVID-19 pandemic, the Veterans Health Administration (VHA) instituted a national policy converting screening colonoscopy to fecal immunochemical testing (FIT) to manage reduced access
Endocuff Vision Effective in “Real-World” Experience
Endocuff Vision (ECV; Olympus America, Center Valley, Pa) has produced adenoma detection rate (ADR) gains in randomized controlled trials, but it has not received widespread
Protein Assays Added to the Fecal Immunochemical Test Improve Sensitivity for Advanced Adenomas
The fecal immunochemical test (FIT) is widely chosen by organized colorectal cancer (CRC) screening programs as the screening test of choice. FIT detects about 80%
Colonoscopy More Effective Than the Fecal Immunochemical Test in Case-Control Study
Randomized controlled trials comparing the use of colonoscopy to the fecal immunochemical test (FIT) for colorectal cancer (CRC) screening are underway. A case-control study from
Bad Outcomes for Patients Not Undergoing Colonoscopy After Positive Fecal Immunochemical Test
In an Italian study using a fecal immunochemical test (FIT)-positivity cutoff of 20 µg Hb/g feces, 88,013 FIT-positive patients (79%) underwent colonoscopy, and 23,410 (21%)
Adherence To Colonoscopy After Positive Fecal Immunochemical Testing Is Related To Patient Navigation and Distance From Center
In a comparison of colonoscopy adherence after positive fecal immunochemical testing (FIT) in 2017 without patient navigation (PN) versus 2018 with navigation, overall completion of
Adenoma Detection Rate Can Be Measured in Combined Screening, Surveillance, and Diagnostic Examinations
When the adenoma detection rate (ADR) was originally proposed as a quality measure in 2002, the recommendation did not constrain its indication to screening colonoscopies
Screening With Fecal Immunochemical Test More Impactful for Distal Than Proximal Cancers
In a nationwide biennial fecal immunochemical test (FIT) screening program in Taiwan, more than 5.4 million individuals were invited to undergo screening between 2004 and
Kaiser Achieved Greater Than 80% Screening Adherence; How Did They Do It?
Organized screening, in which a nation or health care system systematically offers colorectal cancer screening for eligible patients, usually by fecal immunochemical testing (FIT), is
Negative Colonoscopy for FIT-Positive Patients: Should We Keep Doing FIT?
In this study from Taiwan, patients with a negative colonoscopy after a positive fecal immunochemical test (FIT) during the interval 2004 through 2009 were followed
Risk of Death From Colonoscopy in the Italian FIT Screening Program
Organized fecal immunochemical test (FIT)-based screening programs offer the opportunity to prospectively assess adverse events of colonoscopy. A recent large study from the Netherlands found
Early Colorectal Cancer Screening in African Americans: High Uptake and High Yield
Recommendations from GI societies to screen African Americans for colorectal cancer (CRC) starting at age 45 were based largely on age-related incidence and mortality data
Considering Endoscopy in Iron Deficiency Anemia? Don’t Rely on Fecal Blood Testing to Decide
Douglas K. Rex, MD, FASGE, reviewing Lee MW, et al. Am J Gastroenterol 2020 Jan 10. Fecal blood testing is approved as a colorectal cancer
Improving the Message of Mailed Outreach Improves CRC Screening Adherence
Douglas K. Rex, MD, FASGE, reviewing Bakr O, et al. Clin Transl Gastroenterol 2020 Jan. Mailed outreach, in which a fecal immunochemical test (FIT) kit